Kyn not only inhibits the anticancer immune response by inhibiting the proliferation of functional T cells [28] but also constitutively activates AhR, which has been confirmed as an effective contributor to tumor progression and EMT [29–31]. This evidence concerns the gene AHR and neoplasm.